EUCTR2007-004714-14-DK进行中（未招募）不适用
The effect of glitazone-treatment on bone turn-over and bone marrow cells
Aarhus University Hospital, Aarhus Sygehus0 个研究点开始时间: 2007年9月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •-Postmenopausal as defined by 2 years menopause
- •-Age 60-75
- •-Informed conscent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Osteoporosis (T-score<-2,5 in hip or lumbar spine or previous low impact fractures except fracture of fingers, toes, face, ribs, clavicle)
- •-Endocrinological disease
- •-Treatment with bone active drugs: Hormone replacement therapy within last two years, antiosteoporotic treatment, peroral or intravenous corticosteroidhormone treatment equivalent to more than 1g of prednisolone within last year, antidiabetic treatment.
- •-Congestive or ischaemic heart disease
- •-Ongoin malignant disease or malignant disease within last 5 years except basocellular carcinoma of the skin.
- •-Anaemia 8p-hemoglobin < lower normal level)
- •-Renal disease (p-creatinine > upper normal level)
- •-Liver disease (transaminases > 2 x upper normal level, alkaline phosphatase > upper normal level)
研究者
相似试验
已完成
不适用
Effects of pioglitazone on bone formation and resorption markers in type 2 diabetes mellitus.JPRN-UMIN000023805niversity of Occupational and Environmental Health, Japan60
已完成
2 期
The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow CellsChange in Bone Mineral DensityChange in Bone Marrow Fat ContentNCT00609362University of Aarhus57
进行中（未招募）
1 期
Does an approved treatment for type 2 diabetes decrease the risk of fractures in patients with type 2 diabetes?Type 2 diabetes mellitusMedDRA version: 19.0Level: LLTClassification code 10029505Term: Non-insulin-dependent diabetes mellitusSystem Organ Class: 100000004861EUCTR2015-001284-40-DKAarhus University Hospital60
进行中（未招募）
不适用
An observational study to find the effects of anti diabetic medications on bone turnover markers and fracture risk in patients with type 2 diabetes mellitusCTRI/2019/04/018599Indian Council of Medical Research
已完成
不适用
Effect of Zolendronate in patients of celiac diseaseCTRI/2015/06/005863Dr Sanjay Kumar Bhadada50